Results 51 to 60 of about 106,049,057 (196)

Current clinical application of serum biomarkers to detect and monitor ovarian cancer – update

open access: yesMenopause Review, 2022
In recent decades many potential serum biomarkers have been assessed in the diagnosis of ovarian cancer. Except cancer antigen 125 (CA125) and human epididymis protein 4 (HE4), none of them have been applied to everyday clinical practice.
Łukasz Janas, Ewa Kalinka, Marek Nowak
doaj   +1 more source

Single‐Cell Insights Into Pathogenic Profile of Orchitis and SREBP2‐Associated Cholesterol Dysregulation in Spermatogenic Failure

open access: yesAdvanced Science, EarlyView.
A first single‐cell atlas of human orchitis reveals coordinated germ‐cell loss, somatic niche dysfunction, and immune‐metabolic remodeling. Aberrant SREBP2 activation in testicular somatic cells emerges as a central pathogenic node, while Fatostatin‐mediated inhibition of the SREBP pathway improves spermatogenesis, fibrosis, and lipid accumulation in a
Yanlin Tang   +16 more
wiley   +1 more source

FADS2‐STING Signaling in Sertoli Cells Orchestrates Collagen Deposition and Germ Cell Necroptosis in Idiopathic Non‐Obstructive Azoospermia

open access: yesAdvanced Science, EarlyView.
In Sertoli cells of iNOA testes, downregulation of FADS2 activates STING, promoting collagen deposition and peritubular fibrosis while increasing germ‐cell susceptibility to necroptosis. Supplementation with FADS2‐derived PUFAs (GLA and DHA) inhibits STING, alleviates collagen accumulation, and facilitates the recovery of spermatogenesis.
Jiajing Lin   +15 more
wiley   +1 more source

Serum human epididymis protein 4 vs. carbohydrate antigen 125 in ovarian cancer follow-up

open access: yes, 2018
The addition of human epididymis protein 4 (HE4) to carbohydrate antigen 125 (CA125) in ovarian cancer (OC) assessment has been proposed. We compared the clinical value of biomarker changes in a prospective series of patients undergoing OC ...
S. Ferraro   +16 more
core   +1 more source

HE4 in the Diagnostic Approach of Endometrial Cancer in Patients with Postmenopausal Bleeding, the METRODEC Protocol: Protocol for a Multicenter Prospective Study

open access: yesDiagnostics, 2021
Background: Endometrial cancer is the most common pelvic gynecological cancer in France. The most frequent symptom is post-menopausal bleeding and is one of the primary reasons for consultation in gynecological emergencies. The treatment is very codified
Manon Degez   +11 more
doaj   +1 more source

Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer

open access: yesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
The purpose of this study was to evaluate the prognostic significance of serum human epididymis protein 4 (HE4) level in patients with epithelial ovarian cancer.A total of 78 women diagnosed with a pelvic mass and operated on in our institute comprised our cohort.
Jiheum, Paek   +7 more
openaire   +3 more sources

Metformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Metformin preconditioning enhances the migratory and therapeutic efficacy of adipose‐derived mesenchymal stem cells, promoting remyelination in a cuprizone‐induced mouse model. This effect is mediated by decorin‐driven modulation of the TGF‐β/CTGF signaling axis and extracellular matrix remodeling.
Fatemeh Taghizadeh   +5 more
wiley   +1 more source

Interaction of HE4 and ANXA2 exists in various malignant cells—HE4–ANXA2–MMP2 protein complex promotes cell migration

open access: yesCancer Cell International, 2019
Background The interaction between human epididymis protein 4 (HE4) and annexin A2 (Annexin A2) has been found in ovarian cancer. However, it is dimness whether the interaction exists in other malignant tumors. Methods Real-time PCR, western blotting and
Jing Wang   +9 more
doaj   +1 more source

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

open access: yesiNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid   +4 more
wiley   +1 more source

Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer

open access: yesTumor Biology, 2017
Primary chemotherapy treatment response monitoring in advanced epithelial ovarian cancer (EOC) is currently based on CT-imaging and serum CA125 values. Serum HE4 profile during first line chemotherapy has not been previously studied. We evaluated the HE4
Tuulia Vallius   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy